Actively Recruiting

Age: 18Years +
All Genders
NCT07059026

Thrombotic Microangiopathy (TMA) Associated With Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adult Patients

Led by ITAC (Instituto de Trasplantes y Alta Complejidad) · Updated on 2025-07-14

200

Participants Needed

1

Research Sites

156 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Thrombotic Microangiopathy (TMA) Associated with Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) is a serious complication that is associated with increased morbidity, related to multiple organ failure, with increased mortality in transplant patients. The incidence and evolution of TMA, especially in the adult population, is unclear due to the lack of early systematic screening and clear criteria for its diagnosis. For this reason, we designed this protocol to study the incidence and evolution of TMA Associated with allogeneic HSCT in adult patients from Argentina.

CONDITIONS

Official Title

Thrombotic Microangiopathy (TMA) Associated With Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adult Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients (18 years or older) undergoing allogeneic HSCT in specialized centers with routine clinical/laboratory screening for TMA
  • Patients with three or more laboratory or clinical markers of TMA in two consecutive assessments within 14 days, including: elevated schistocytes in blood, LDH above normal, new thrombocytopenia or need for platelet transfusion, new anemia or need for red blood cell transfusion, high blood pressure (≥140/90), or proteinuria
  • Patients suspected or diagnosed with TMA who have signed specific study consent
Not Eligible

You will not qualify if you...

  • Participation in any interventional treatment study for TMA

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Instituto de Trasplantes de Alta Complejidad (ITAC)

Buenos Aires, Argentina, C1425EGH

Actively Recruiting

Loading map...

Research Team

M

Maria Belen Rosales Ostriz, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here